FDA Drug Application (077317) for ISRADIPINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number077317
Product Number001
FormCAPSULE;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameISRADIPINE
Active IngredientISRADIPINE

Active IngredientCount
List of drugs with Active Ingredient ISRADIPINE3


Back to FDA Applications sponsored by WATSON LABS